https://www.marketscreener.com/quote/stock/MERCK-CO-INC-13611/news/Merck-Announces-Pivotal-Phase-3-Study-of-Letermovir-an-Investigational-Antiviral-Medicine-for-Pre-23237154/?utm_source=telegram&utm_medium=social&utm_campaign=share